✦ LIBER ✦

Evaluation of a Neurokinin1 antagonist, CP-99,994, in comparison to ibuprofen and placebo in the oral surgery model.

✍ Scribed by Dionne, R.A.; Max, M.B.; Parada, S.; Gordon, S.M.; MacLcan, D.B.

Book ID: 110019804
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 154 KB
Volume: 59
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.1996.365

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Additive analgesic effects of oxycodone

Additive analgesic effects of oxycodone and ibuprofen in the oral surgery model

✍ Raymond A Dionne 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 815 KB

A double-blind, repeat-dose, parallel st

A double-blind, repeat-dose, parallel study comparing the efficacy and safety of a controlled release ibuprofen to placebo in postoperative oral surgery pain

✍ S. Turner; S. Cooper; S. Christensen; P. Brain; G. Podolsky; J. Brown 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

A double-blind, randomized comparison of

A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post—oral surgery pain model

✍ Stephen E. Daniels; Evie H. Grossman; Michael E. Kuss; Sheela Talwalker; Richard 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 908 KB

A Comparison of Ebastine 10mg Fast-Disso

A Comparison of Ebastine 10mg Fast-Dissolving Tablet with Oral Desloratadine and Placebo in Inhibiting the Cutaneous Reaction to Histamine in Healthy Adults

✍ Rosa M. Antonijoan, Consuelo García-Gea, Montserrat Puntes, Marta Valle, Ramon E 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 312 KB

Comparison of the analgesic efficacy of

Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: A randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-center, modified factorial study

✍ Donald R. Mehlisch; Sue Aspley; Stephen E. Daniels; Donald P. Bandy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 880 KB

A phase IIb dose-ranging study of the or

A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone

✍ Joel M. Kremer; Stanley Cohen; Bethanie E. Wilkinson; Carol A. Connell; Jonathan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB